CH5164840 exhibits potent antiproliferative activity against human cancer cell lines (HCT116 IC50 = 0.15 μM; NCI-N87 IC50 = 0.066 μM); demonstrates strong antitumor activity with good oral bioavailability (t1/2 = 2.64 h); and shows high binding affinity for the N-terminal domain of Hsp90α (Kd = 0.52 nM).